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Objectives: Near-infrared spectroscopy provides a noninvasive method of measuring tissue oxygen saturation and has been
used to monitor extremity compartment syndrome. Tissue O2 saturation (StO2) is potentially useful in assessing patients
with peripheral arterial disease (PAD). The purposes of this feasibility study are to (1) explore the diagnostic sensitivity
of StO2 in subjects with PAD and symptoms of intermittent claudication (IC) compared with normal subjects, and (2)
correlate the change in StO2 during and after exercise with the ankle brachial index (ABI) in patients with IC.
Material and methods: Forty-nine subjects, 35 normal and 14 PAD, from two centers were evaluated in a prospective
cross-sectional analysis comparing StO2 by using the InSpectra tissue spectrometer and ABI at rest (baseline) and after
treadmill exercise. Measurements were obtained at baseline and peak exercise (normal subjects) and at baseline, initial
claudication distance (ICD) and absolute claudication distance (ACD) in PAD subjects. Endpoint values were the mean
of 15 data points. Times to 50% of StO2 recovery to baseline (T50) and complete recovery to baseline (T100) were
measured. Receiver-operator characteristic curves were constructed to assess the sensitivity/specificity values associated
with various StO2 cut-points.
Results: The PAD patients were older (P .0002) and 57% were male, compared with 37% males in the normal group. The
ABI was 0.68  0.14 in PAD patients versus 1.14  0.08 in normal subjects (P < .0001). The baseline StO2 was 65% in
both groups. The peak exercise StO2 was significantly lower and the absolute change in StO2 and the percent change in
StO2 were significantly greater in PAD patients (P < 0.45). The T50 and T100 were longer in the PAD patients compared
to normal subjects (P  .0001 and .002, respectively). A T50 of >70 seconds yielded a sensitivity of 89% and a specificity
of 85% for PAD.
Conclusions: StO2 is a new and potentially useful technique to evaluate patients with PAD. Resting StO2 was similar in
PAD-IC subjects and normals. There was a significantly greater drop in StO2 and longer recovery times in PAD-IC
subjects. Interestingly, StO2 at the ICD and ACD was similar. StO2 offers a different and perhaps more appropriate end
point for diagnosis and monitoring of the management of patients with PAD, and may offer additional insight into the
pathophysiology of exercise-induced muscle ischemia and its recovery. (J Vasc Surg 2003;38:724-9.)
Lower-extremity peripheral arterial disease (PAD) af-
fects approximately 8 to 10 million individuals in the
United States.1 Intermittent claudication (IC) is the most
common symptom of lower-extremity PAD, with approx-
imately one third to one half of the afflicted individuals
having symptoms. The annual incidence of IC is approxi-
mately 15.5 new cases per 1000 individuals.1,2
The diagnosis of peripheral arterial disease can gener-
ally be established with a good history and physical exami-
nation, especially if an ankle brachial index (ABI) is in-
cluded as part of the physical examination. Segmental limb
pressures are frequently performed by vascular laboratories
and complement the ABI. Although the ABI is relatively
easy to perform, its sensitivity declines from approximately
80% for severe stenosis in one or more peripheral arteries to
approximately 50% for mild disease.3 Patients with medial
calcinosis will have falsely elevated lower limb pressures,
and approximately one third of diabetics will have falsely
elevated ABIs. In the absence of calcification, the ABI is a
good measure of perfusion pressure; however, it is not an
indicator of skeletal muscle ischemia, and it does not cor-
relate with walking distance.
Near-infrared spectroscopy (NIRS) technology is used
daily by clinicians to monitor the oxygenation of blood in
patients at risk of hypoxia. NIRS can also provide a measure
of local tissue oxygenation.4-6 Despite its potential value as
a direct method of assessing tissue ischemia resulting from
arterial occlusion, little attention has been given to this
technique for that purpose.
Patients with PAD of their lower extremities have
symptoms of intermittent claudication as a result of exer-
cise-induced muscle ischemia. Therefore, it is intuitively
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appropriate to use muscle oxygen saturation (StO2) as a
functional endpoint in patients with PAD and, in particular,
in patients with IC.
The InSpectra tissue spectrometer (Hutchinson Tech-
nology Inc, Hutchinson, Minn) noninvasively measures
and displays percent tissue StO2, which represents a quan-
tified percent hemoglobin oxygen saturation in a regional
tissue bed. As quantification permits comparison between
individuals, StO2 has potential for providing clinically use-
ful information about patients with ischemia caused by
arterial occlusive disease.
The primary objectives of this prospective, nonran-
domized study were (1) to determine whether a correlation
existed between StO2 of the gastrocnemius muscle and ABI
in patients with previously diagnosed PAD causing IC, and
(2) to estimate the sensitivity of StO2 in identifying PAD in
an individual subject. Secondary objectives were (3) to
characterize the relationship between StO2 and claudica-
tion symptoms, and (4) to evaluate the safety of the InSpec-
tra tissue spectrophometer when used to screen for PAD.
METHODS
The study was approved by the Institutional Review
Board of Temple University Hospital (Philadelphia, Pa)
and by the Western Institutional Review Board (Olympia,
Wash) for the Heart and Vascular Institute (Morristown,
NJ), and each patient signed an informed consent.
Two groups of subjects were recruited for this study:
normals, defined as individuals having no history or evi-
dence of PAD, and PAD subjects whose PAD causing
intermittent claudication (PAD-IC) (Rutherford Grade I)
was diagnosed by vascular experts on the basis of history,
physical examination, and noninvasive studies. Of the 49
subjects enrolled, 14 had PAD-IC and 35 were considered
normal.
Subjects were evaluated at rest and then performed a
modified Gardner treadmill protocol, walking eight
2-minute stages for a maximum of 16 minutes. The tread-
mill speed was maintained at 2.0 mph for all stages. The first
stage was at 0% grade, and every 2 minutes, the grade was
increased 2% until a maximum grade of 14% was reached.
IC subjects were instructed to report their onset of symp-
toms (IC distance [ICD]) and the point at which they
could no longer ambulate (absolute claudication distance
[ACD]). Ankle brachial indices were collected prior to
treadmill walking and every 5 minutes after exercise. The
leg with the lowest ABI was selected as the test leg in
subjects with bilateral disease. The pre-exercise ABI was
considered the diagnostic ABI and used for comparison to
baseline StO2.
StO2 was monitored with the InSpectra Tissue Spec-
trometer-Model 325 by means of a 35-mm light emitting/
collection head attached to an optical cable placed over the
selected site of the gastrocnemius muscle on the test leg.
The muscle was “mapped” with the device to locate the site
with the highest observed StO2 reading . The device was
adhered by means of a double-adhesive light-excluding
collar and allowed to equilibrate for 5 minutes to obtain
baseline reading prior to the exercise walk. Values were
recorded every 3.5 seconds throughout baseline, ICD and
ACD, or conclusion of a maximum 16-minute walk (nor-
mals), and for a minimum of 20 minutes for StO2 recovery
time. Baseline, ICD, ACD, and peak exercise values were
represented by a mean of 15 measurements. Absolute and
percent changes between baseline and peak exercise were
calculated by using the baseline and peak exercise end-
points. T50 and T100 were estimated from a logistic growth
curve equation estimated from the recovery StO2 data.




3. Absolute and percent change between baseline and peak
exercise
4. StO2 at ICD and ACD
5. Time elapsed from peak exercise to 50% StO2 recovery
(T50)
6. Time elapsed from peak exercise to 100% StO2 recovery
(T100).
STATISTICAL ANALYSIS
The Wilcoxon rank sum test (continuous variables) and
the Fisher exact test (categorical variables) were used to test
for distributional differences in demographic parameters
between the study groups. To demonstrate a correlation
between StO2 and ABI, a Pearson’s correlation coefficient
was estimated and a linear regression model was fit to the
data in order to incorporate possible confounders into the
analysis and assess their effect on the relationship between
ABI and various StO2 endpoints. The effect of age and BMI
were considered as possible confounders because they dif-
fered significantly among the study groups. Gender was
also considered a confounder on the basis of historical
differences. Analysis of variance models (one without the
inclusion of the covariates and one with the inclusion of the
covariates) were fit to the data to test for significant differ-
ences in the StO2 endpoints between the study groups.
This was the first step in identifying the StO2 endpoints and
associated cut-points that would differentiate the groups
into PAD-IC and normal to obtain initial estimates of
sensitivity and specificity. The ICD and ACD values were
paired within subject, and the mean difference was com-
pared to zero by using the Wilcoxon signed rank test. In
addition, P values for the correlation and comparison of
study group objectives were compared to an  value of
.0071 (.05/71, Bonferroni method)
7 to correct for multi-
plicity.
RESULTS
The demographic information on the subjects is listed
in Table I. Age at enrollment, body mass index, and lower-
extremity ischemia category differed significantly between
the PAD-IC subjects and the normal group. PAD-IC sub-
jects (67  15 years) were significantly older and had a
higher body mass index (27.6  3.4) than the normal
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subjects (age 43 15 years, BMI 24.9 27). As expected,
PAD-IC subjects had lower-extremity ischemia categories
consistent with intermittent claudication, and normal sub-
jects did not. Height, weight, gender, and race were not
found to be different between the groups.
The results for the parameters measured are presented
in Table II, which reports the mean (SD) and 95%
confidence intervals of StO2 endpoints for PAD-IC sub-
jects and normal subjects. As expected, there was a signifi-
cant difference in the resting ankle brachial index; however,
there was no difference in StO2 measurements at rest. The
StO2 values versus ABI plotted over time are depicted in
Fig 1 for the normal group and Fig 2 for PAD patients.
Peak exercise StO2 was significantly lower in the PAD-IC
Table I. Demographics overall and for PAD-IC and normal subjects, (mean  SD)
Parameter PAD-IC (n  14) Normal (n  35) P value*
Age (y) 67  15 43  15 .0002
Years since PAD diagnosis 3.1  2.8 NA NA
Height (in.) 66  4 66  5 .7239
Weight (lbs.) 170  23 159  37 .1102
BMI 27.6  3.4 24.9  2.7 .0104
Ethnic origin
Asian/Pacific Islander 0 (0%) 0 (0%)
Black 4 (29%) 6 (17%)
Caucasian 10 (71%) 26 (74%)
Hispanic 0 (0%) 1 (3%)
Other 0 (0%) 2 (6%) .6394
Gender
Male 8 (57%) 13 (37%)
Female 6 (43%) 22 (63%) .2219
Tobacco use
No 12 (86%) 31 (89%)
Yes 2 (14%) 4 (11%) 1.0000
Average # of years for tobacco users 52  2 10  7 NE
†
Rutherford lower extremity ischemia category
Grade 0, Category 0, asymptomatic 0 (0%) 34 (97%)
Grade I, Category 1, mild claudication 6 (43%) 0 (0%)
Grade I, Category 2, moderate claudication 4 (29%) 0 (0%)
Grade I, Category 3, severe claudication 3 (21%) 0 (0%)
Missing 1 (7%) 1 (3%) NE
†
PAD, Peripheral arterial disease; IC, intermittent claudication.
*Wilcoxon rank sum test (t approximation) used for continuous variables. Fisher exact test used for categorical variables.
†
Comparison between groups not evaluated.
Table II. Mean (SD) and 95% CI of StO2 endpoints for PAD-IC and normal subjects
Parameter
PAD-IC (n  14) Normal (n  35)
P Value
†
Mean  SD 95% CI* Mean  SD 95% CI
Baseline ABI 0.68  0.14 0.60–.76 1.14 0.08 1.11–1.17 .0001
Postexercise ABI 0.40  0.21 0.27–.52 1.13  0.13 (n  34) 1.09–1.18 .0001
Baseline StO2 (%) 65  28 49–81 65  19 58–71 .9812
Duration of Exercise (min) 9.0  4.8 (n  12) 16.0  0.5 (n  34) .0001









76  31 (n  10) 54–98 52  32 (n  34) 41–64 .0454
T50 (seconds) 104  39 (n  9) 74–134 55  23 (n  33) 47–63 .0001
T100 (seconds) 203  69 (n  8) 146–261 117  63 (n  27) 92–142 .0020
Recovery as a Percent of
Baseline
117  64 (n  12) 77–158 119  37 (n  34) 106–132 .8951
PAD, Peripheral arterial disease; IC, intermittent claudication; StO2, muscle oxygen saturation; ABI, ankle brachial index.
*95% Confidence interval (CI) based on normal approximation.
†
F test for variable indicating PAD-IC and normal status (not corrected for cavariates).
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group. The absolute change in StO2 between baseline and
peak exercise as well as the percent change from baseline to
peak exercise was significantly greater in the PAD-IC group
compared with the normal group. However, the peak exer-
cise, absolute, and percent change in StO2 results did not
persist once the covariates of age and gender were included in
the model. The StO2 recovery time was significantly longer
both at the 50% value (T50) and time to return to baseline
Fig 1. Mean SEM for muscle oxygen saturation (StO2) and ankle brachial index (ABI) throughout exercise protocol
for normal subjects (n  35).
Fig 2. Mean SEM for muscle oxygen saturation (StO2) and ankle brachial index (ABI) throughout exercise protocol
for PAD-IC subjects (n  14).
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(T100) in the PAD-IC group. These results did maintain
statistical significance upon inclusion of covariates and upon
correction for multiplicity by using the Bonferroni method.
A significant correlation was found between ABI and
T50 (r   .65, P value  .0001) and T100 (r  .48, P
value  .0035). These results maintained statistical signif-
icance upon inclusion of covariates and upon correction for
multiplicity by using the Bonferroni method (Table III,
online only).
Receiver-operator characteristic curves (ROC) were
used to assess the sensitivity and specificity values associated
with various StO2 cut-points. Sensitivity was defined as the
proportion of subjects testing positive for PAD-IC status
when an StO2 endpoint was used for the subjects known to
have PAD-IC in the study. Specificity was defined as the
proportion of subjects testing negative for PAD-IC status
when an StO2 endpoint was used for the subjects known to
be normal in the study. The StO2 endpoints used to differ-
entiate the groups were T50 and T100 based on the strength
of the ROC results. The T50 cut-point maximizing sensi-
tivity without losing specificity was T50  70 seconds,
which yielded a sensitivity of 89% (8/9) and a specificity of
85% (28/33). When T100 was evaluated, a value of 165
seconds gave the best sensitivity/specificity estimate of 88%
(7/8) and 81% (22/27), respectively.
The ICD and ACD in PAD patients are listed in Table IV.
There is no significant difference between the two values.
There were no adverse events when the InSpectra tissue
spectrometer was used, further supporting the safe use of
this noninvasive, painless device.
DISCUSSION
NIRS is based on the ability of tissue to absorb infrared
light. Light in the near-infrared spectrum passes easily
through skin and bone; however, it is variously absorbed by
tissues containing blood. This is predominantly determined
by chromophores in tissue whose capacity to absorb infra-
red light is dependent on oxygen content. Changes in the
amount of near-infrared light reflected by tissue can be
analyzed to detect the percentage oxygen saturation of
hemoglobin in tissue (muscle). It is reasonable to apply this
technology to the evaluation of patients afflicted with any
condition or disease causing tissue ischemia.
The primary objectives of this study were to evaluate
the correlation of StO2 with ABI and to estimate the
diagnostic sensitivity of StO2 in differentiating subjects
with and without peripheral arterial disease. We thought
that a 16-minute Gardner protocol would reveal the muscle
ischemia in PAD patients while being a vigorous but not
necessarily fatiguing exercise for subjects in the normal
group.
The resting StO2 did not correlate with resting ABI in
PAD-IC patients compared to the normal group. This is
not surprising, and actually, it was anticipated, because it is
known that leg blood flow at rest is not different in PAD-IC
patients compared with normal subjects. However, there
was a significant difference in the peak exercise StO2, both
in terms of an absolute drop and a relative change in StO2,
and a significant difference in their recovery times, both at
T50 and T100, when PAD-IC patients are compared with
normal subjects. The exercise results did not persist once
the model was expanded to include covariates (age, BMI,
gender). Therefore, it is not statistically possible to know
whether the difference found was due to PAD status or age,
although in the authors’ opinion, PAD status was the
significant factor. As the T50 and T100 results persisted after
incorporation of the covariates, this assumption appears
well founded. The accuracy of StO2 in detecting PAD-IC
versus normal was good, yielding an 89% sensitivity and
85% specificity with a T50 of 70 seconds. Because of the
relatively small number of enrolled subjects, validation of
these initial estimates is not possible.
Using venous occlusion plethysmography to calculate
muscle blood flow, other investigators included NIRS to
evaluate oxygen consumption, oxygen resaturation, and
recovery times.7 These investigators also observed a high
correlation of oxyhemoglobin recovery time with the ABI
after walking exercise, concluding that NIRS appeared to
be an effective, noninvasive method of evaluating oxygen
demand and delivery in leg muscles of PAD patients at rest
and during exercise. The NIRS technology used by Kooij-
man et al8 was different than that used in this study, in that
those investigators measured relative changes in the oxy-
genation of the chromophores involved with oxygen bind-
ing rather than a quantitative oxygen saturation of muscle
tissue. We believe that the quantitative method used in this
study offers the advantage of comparison among patients,
patient groups, and disease states.
The design of this study incorporated maximal exercise
for PAD-IC patients and vigorous exercise in normal sub-
jects (through eight stages of a Gardner protocol). Evalu-
ating the response of both groups raises the question as to
whether a much less vigorous exercise would be more
appropriate and raises the question as to whether the slope
of the fall in oxygen saturation during graded submaximal
Table IV. Initial claudication distance (ICD) and absolute claudication distance (ACD) and the associated muscle
oxygen saturation (StO2) values and walking times in PAD patients
ICD
(mean  SD) 95% CI
ACD
(mean  SD) 95% CI P value*
StO2 10  11 (n  8) 3-18 8  11 (n  8) 0-18 .27 (n8)
Walking time 5.9  3.9 (n14) 3.7-8.2 7.6  3.9 (n10) 4.8-10.4
*Wilcoxon signed rank test.
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exercise might be a better indicator of ischemia caused by
arterial occlusive disease, especially in patients with IC.
Figure 2 graphically shows the significant drop in StO2
with exercise in PAD patients, a drop that is many magni-
tudes greater than the corresponding drop in ABI, which
suggests improved sensitivity in detecting exercise-induced
muscle ischemia and improving the evaluation of patients
with intermittent claudication.
There was overlap in the exercise StO2 endpoints in
some normal subjects with PAD-IC patients. Some normal
subjects had their StO2 fall to unexpectedly low levels. It is
possible that some of these normal subjects had subclinical
arterial occlusive disease not previously detected and that
any fatigue or aching response to exercise was attributed as
a normal response to vigorous ambulation rather than as a
suspicion of underlying pathology.
StO2 has been investigated in the diagnosis and man-
agement of patients with compartment syndrome of the
leg, because muscle ischemia is the basis for intervention.
Similar to patients with PAD, patients with compartment
syndrome may have reduced systemic oxygen delivery,
which might affect StO2 readings. Arbabi et al
9 demon-
strated in an animal model that StO2 clearly differentiated
the muscle ischemia caused by systemic hypoxemia and
shock from that caused by the more advanced ischemia of
compartment syndrome. Giannotti et al10 reported on the
use of NIRS-derived StO2 values in the lower extremities of
trauma patients with compartment syndromes. They dem-
onstrated that StO2 was diminished in patients with com-
partment syndrome and normalized after fasciotomy. Van
den Brand et al11 report significant differences in average
peak exercise values and percent change from baseline
between patients with chronic exertional compartment syn-
drome (CECS) and normal subjects. Interestingly, the
StO2 values of patients with CECS returned to the normal
range postfasciotomy. As muscle ischemia is the important
component in both compartment syndrome patients and
PAD-IC patients, StO2 measurements would appear to
have substantial utility in both groups.
The observations made in this feasibility study of nor-
mal subjects and PAD-IC subjects raise more questions
than are answered regarding the utility of this technique.
Modifying the investigative method, evaluating the effect
of systemic hypoxemia on exercise response, studying pa-
tients during submaximal exercise, and studying the proper
application of StO2 in patients with critical limb ischemia
before and after revascularization are but a few of the
potential areas of investigation. As StO2 is a direct assess-
ment of tissue oxygen saturation, it has significant potential
to offer insight into the pathophysiology of a wide variety of
conditions causing peripheral ischemia, especially exercise-
induced muscle ischemia and its recovery.
We gratefully acknowledge Teresa Nelson, MS, at
RCRI, for statistical analysis and Diane Rupp of Hutchin-
son Technology for her technical advice.
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